![Page 1: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/1.jpg)
![Page 2: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/2.jpg)
2
![Page 3: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/3.jpg)
3
1 Company Overview
2 Hanmi R&D
3 Beijing Hanmi
4 Financial Results
5 Appendix
![Page 4: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/4.jpg)
4
(Automated Drug Packaging System Company)
![Page 5: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/5.jpg)
805.0
187.1 162.6 170.7
192.9 209.8
0
200
400
600
0
500
1,000
1,500
2015 2016 2017 2018 2019
Sales R&D
1,317.5(Incl. Upfront/Milestones)Sales
(bn KRW)R&D
(bn KRW)
14.2%18.4% 18.6%
19.0%18.8%
5
916.6882.7
1,016.0
1,113.6
Upfront/Milestones
![Page 6: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/6.jpg)
6
![Page 7: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/7.jpg)
7
![Page 8: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/8.jpg)
8
AG
LYCO
SYLATED
FC
AG
LYCO
SYLATED
FC
AG
LYCO
SYLATED
FC
AG
LYCO
SYLATED
FC
Longer Duration
Efficacy & Safety ↑
![Page 9: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/9.jpg)
9
Key Features
Seeking collaboration opportunities
![Page 10: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/10.jpg)
Pre-clinical Phase 1 Phase 2 Phase 3 Registration
Obesity/NASH/Diabetes
LAPSGlucagon ComboHM14320Obesity/Diabetes/NASH
LAPSTriple AgonistHM15211NASH
LAPSGLP/GCGHM12525AObesity
LAPSExd4 AnalogEfpeglenatideDiabetes
LAPSInsulin ComboHM14220Diabetes
LAPSGlucagon AnalogHM15136Obesity
LAPInsulin148HM12480Diabetes
LAPSInsulinHM12460A/HM12470Diabetes
Oncology
EZH1/2 Inhibitor
Solid tumor
Pan-RAF InhibitorBelvarafenibSolid tumor
Pan-HER InhibitorPoziotinibSolid tumor
Oraxol™Paclitaxel+encequidarBreast cancer, solid tumor
LAPSGCSF AnalogEflapegrastimNeutropenia
LSD1 Inhibitor
SCLC, AML
FLT3 InhibitorHM43239AML
Oratecan™Irinotecan+encequidarSolid tumor
ADOR Antagonist
Solid tumor
PD-1/HER2 BsAbBH2950Solid tumor
Oradoxel™Docetaxel+encequidarSolid tumor
GBM Stem Cell TherapyHM21001Glioblastoma
FLX475 (CCR4 Inhibitor)
Solid tumor
Immuno-oncology BsAb
Solid tumor
PD-L1/CD47 BsAb
Solid tumor, Hematologic cancers
Rare Diseases/Other
LAPSASBHM15450Mucopolysaccharidosis
LAPSGlucagon AnalogHM15136Congenital Hyperinsulinism
LAPShGHEfpegsomatropinGH deficiency
LAPSGLP-2 AnalogHM15912Short Bowel Syndrome
Luminate®
Integrin inhibitorDME
Luminate®
Integrin inhibitorRetinitis Pigmentosa
BTK InhibitorHM71224Autoimmune disease 10
B
B
B
B Beijing Hanmi
![Page 11: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/11.jpg)
11
Delivering double-digit growth in domestic market with core
value-added products
Launching 2~3 value-added products annually
Seeking partners for emerging markets
Domestic business growth
2019
Hanmi
597.6
551.8
2018
578.7
2017
526.8
2016
805.0882.7
916.6
1,016.0
675.4
1,113.6
2015
13.0%Korea
Total
Top value-added products
*IMD (Incrementally Modified Drug); **FDC (Fixed Dose Combination)
![Page 12: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/12.jpg)
12
Sales force 1,000+
About 70% : Doctors and Pharmacists
Directly covering 9,000 hospitals and over
150,000 doctors, keeping the No.1
position in pediatric drug market.
Sales & MarketingManufacturingBeijing R&D center
New Biologics BIO ProductionNCE
- Auto-immune
- Oncology
- Diabetes
- Obesity
- Oncology
- PENTAMBODY
PhD. 5, MS. 74
Est. Oct 2008
Animal facility for rodents, beagles,
and primates
High-tech enterprise certification
Focus areas
R&D staffs 150+ GMP sites
To provide FPP to
Chinese market
![Page 13: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/13.jpg)
13
![Page 14: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/14.jpg)
14
![Page 15: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/15.jpg)
15
DEC
![Page 16: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/16.jpg)
16
![Page 17: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/17.jpg)
17
![Page 18: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/18.jpg)
18
![Page 19: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/19.jpg)
19
164.839.90.012.2
![Page 20: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/20.jpg)
20
![Page 21: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/21.jpg)
21
![Page 22: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/22.jpg)
22
24.2% 13.0%
39.7% 11.7%
16.4% -7.5%
12.1% -4.5%
21.0% 15.1%
35.1% 13.8%
12.9% -5.4%
8.8% -2.3%
![Page 23: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/23.jpg)
23
22.2%
59.8%
70.9%
-15.3%
![Page 24: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/24.jpg)
24
15.1% 10.5%
8.8% 5.8%
17.3% 13.9%
11.4% 7.6%
15.6% 8.1%
-7.9% -11.3%
7.2% -15.1%
13.4% 24.5%
![Page 25: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/25.jpg)
25
![Page 26: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/26.jpg)
26
![Page 27: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/27.jpg)
27
![Page 28: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/28.jpg)
28
![Page 29: 1 Company Overvie...12 Sales force 1,000+ About 70% : Doctors and Pharmacists Directly covering 9,000 hospitals and over 150,000 doctors, keeping the No.1 position in pediatric drug](https://reader035.vdocuments.net/reader035/viewer/2022063018/5fda8db4d5018c2e6b106e1b/html5/thumbnails/29.jpg)